Advertisement
According to the American Medical Association

Competition for Fellowships Broke Records in 2015

0
One-quarter of applicants did not didn't receive a position
For patients receiving chemotherapy

ASCO Updates Guidelines for Antiemetics During Chemo

0
Oral combination of netupitant and palonosetron beneficial for prevention of nausea and vomiting
Off-label drug use puts patients at risk for serious side effects

Prescribing Drugs ‘Off-Label’ Can Pose Serious Safety Risks

0
Study raises concerns about using meds to treat conditions for which they weren't approved

October 2015 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2015. This roundup includes...
Vitiligo can mask symptoms of acanthosis nigricans

Vitiligo Can Mask Symptoms of Acanthosis Nigricans

0
In this case report, masking could have resulted in delay of identification of ovarian cancer
There has been a 25 percent increase in the number of medical school enrollees since 2002

Increasing Numbers of Med School Applicants, Enrollees

0
Med school classes continuing to diversify, with increases in nearly every racial/ethnic category
Colorectal neoplasm is associated with smoking in a dose-response manner

Dose-Response Pattern for Smoking, Colorectal Neoplasm

0
Increase in non-advanced, advanced CRN with increasing smoking; no link for alcohol intake
A synchronized prescription renewal process can save physicians time and money

Synchronized Prescription Renewal Process Saves Time

0
Renewing all patient's stable medications for 12 to 15 months can save time and money
Cancer-associated incidental pulmonary embolism should be treated with low molecular weight heparins

Review Supports LMWH for Cancer-Linked Incidental PE

0
VTE recurrence risk similar under LMWHs, vitamin K antagonists; risk of major hemorrhage up under VKA
For patients with rheumatoid arthritis and inflammatory bowel disease with prior nonmelanoma skin cancer (NMSC)

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

0
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate